Camiel L M de Roij van Zuijdewijn1, Dinky E de Haseth2, Bastiaan van Dam2, Willem A Bax2, Muriel P C Grooteman1, Michiel L Bots3, Peter J Blankestijn4, Menso J Nubé1, Marinus A van den Dorpel5, Pieter M Ter Wee1, Erik L Penne2. 1. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands. 2. Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands. 3. Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, the Netherlands. 4. Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. 5. Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands.
Abstract
BACKGROUND/AIMS: In hemodialysis (HD) patients, the bromcresol green (BCG) assay overestimates, whereas the bromcresol purple (BCP) assay underestimates albumin concentration. Since corrected calcium concentrations depend on albumin, the albumin assay may have implications for the management of bone mineral disorders. METHODS: A subset of patients from CONTRAST, a cohort of prevalent HD patients, was analyzed. Bone mineral parameters and prescription of medication were compared between patients in whom albumin was assessed by BCP versus BCG. RESULTS: Albumin was assessed by BCP in 331 patients (9 of 25 centers) and by BCG in 175 patients (16 of 25 centers). Albumin was the lowest in the BCP group (34.5 ± 4.2 vs. 40.3 ± 3.1 g/L; p < 0.0005). Measured calcium levels and the prescription of calcium-based phosphate binders were similar in both groups. Corrected calcium levels, however, were markedly higher in the BCP group (2.45 ± 0.18 vs. 2.33 ± 0.18 mmol/L; p < 0.0005). CONCLUSION: These findings suggest that calcium levels are not corrected for albumin in clinical practice when considering the prescription of calcium-free or calcium-based phosphate-binders in dialysis patients.
BACKGROUND/AIMS: In hemodialysis (HD) patients, the bromcresol green (BCG) assay overestimates, whereas the bromcresol purple (BCP) assay underestimates albumin concentration. Since corrected calcium concentrations depend on albumin, the albumin assay may have implications for the management of bone mineral disorders. METHODS: A subset of patients from CONTRAST, a cohort of prevalent HDpatients, was analyzed. Bone mineral parameters and prescription of medication were compared between patients in whom albumin was assessed by BCP versus BCG. RESULTS: Albumin was assessed by BCP in 331 patients (9 of 25 centers) and by BCG in 175 patients (16 of 25 centers). Albumin was the lowest in the BCP group (34.5 ± 4.2 vs. 40.3 ± 3.1 g/L; p < 0.0005). Measured calcium levels and the prescription of calcium-based phosphate binders were similar in both groups. Corrected calcium levels, however, were markedly higher in the BCP group (2.45 ± 0.18 vs. 2.33 ± 0.18 mmol/L; p < 0.0005). CONCLUSION: These findings suggest that calcium levels are not corrected for albumin in clinical practice when considering the prescription of calcium-free or calcium-based phosphate-binders in dialysis patients.
Authors: Jessica E Miller; Csaba P Kovesdy; Keith C Norris; Rajnish Mehrotra; Allen R Nissenson; Joel D Kopple; Kamyar Kalantar-Zadeh Journal: Am J Nephrol Date: 2010-09-03 Impact factor: 3.754
Authors: Tamara Isakova; Thomas L Nickolas; Michelle Denburg; Sri Yarlagadda; Daniel E Weiner; Orlando M Gutiérrez; Vinod Bansal; Sylvia E Rosas; Sagar Nigwekar; Jerry Yee; Holly Kramer Journal: Am J Kidney Dis Date: 2017-09-21 Impact factor: 8.860
Authors: Geoffrey A Block; David M Spiegel; James Ehrlich; Ravindra Mehta; Jill Lindbergh; Albert Dreisbach; Paolo Raggi Journal: Kidney Int Date: 2005-10 Impact factor: 10.612
Authors: Maarten B Kok; Frans P W Tegelaers; Bastiaan van Dam; Jan L M L van Rijn; Johannes van Pelt Journal: Clin Chim Acta Date: 2014-04-05 Impact factor: 3.786
Authors: E Lars Penne; Peter J Blankestijn; Michiel L Bots; Marinus A van den Dorpel; Muriel P Grooteman; Menso J Nubé; Ingeborg van der Tweel; Piet M Ter Wee Journal: Curr Control Trials Cardiovasc Med Date: 2005-05-20
Authors: Kathleen M Hill; Berdine R Martin; Meryl E Wastney; George P McCabe; Sharon M Moe; Connie M Weaver; Munro Peacock Journal: Kidney Int Date: 2012-12-19 Impact factor: 10.612